Videos & Webinars

Cell & Gene Therapy Answers: Addressing Challenges and De-risking Development

We recently spoke with Ken Morrison, Global Lead of Operational Strategy & Planning Oncology at Labcorp Drug Development. He shared some of the advantages and challenges of gene therapy, key differences between autologous and allogeneic cell therapies and how to overcome common hurdles to enable effective patient access, recruitment and retention to advance these novel therapeutics.

Filed In

Clinical
Commercialization
Oncology
Patient Recruitment
Regulatory Strategy
Therapies - Cell
Therapies - Gene
Videos & Webinars